USPTO serial 79197477
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, pharmaceutical preparations, and pharmaceutical drugs for medical purposes for prevention of viral and bacterial disease, namely, bacterial vaginosis, herpes simplex virus, human papilloma virus, and human immunodeficiency virus (HIV); chemical preparations for pharmaceutical and medical purposes for the prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus and human immunodeficiency virus (HIV); chemical compounds in the nature of antimicrobial or ph balancing or microbial balancing substances all for medical purposes, namely, for treating and preventing vaginal microbial imbalance, vaginal pH imbalance, vaginal odor and discharge, bacterial vaginosis, viral STD, vaginaitis, vaginal thrush, vaginal disease symptom relief including itching, odor, and discharge, for maintaining a healthy balance of vaginal flora and for the reestablishment of the bacterial vaginal flora; polyvalent compounds and dendrimers sold as integral component parts of pharmaceuticals preparations all for medical purposes for the treatment and prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); antimicrobial preparations, namely, microbicidal preparations in the nature of gels, films, solutions, lubricants for vaginal and rectal use for prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); chemical contraceptives, namely, sponges, gels, foams, creams, films, solutions, suspensions and lotions for use in preventing HIV and other sexually transmitted infections; prophylactic preparations for prevention of pregnancy and microbial disease of the reproductive system, namely, chemical contraceptives and antibacterial preparations in the nature of sponges, suppositories, sexual lubricants, gels, foams, creams, films, solutions, suspensions and lotions; pharmaceutical preparations in the nature of vaginal gels and lubricants all for the prevention of pregnancy and sexually transmitted infections and diseases of the human reproductive system | SECTION 71 - CANCELLED | — |
| 010 | Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 19, 2026 | Further Decision Processed by IB | — | |
| Feb 4, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 4, 2026 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Feb 4, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 13, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 13, 2024 | C71T | CANCELLED SECTION 71 | — |
| May 29, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 7, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 26, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 8, 2018 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 4, 2018 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Nov 28, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 30, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 30, 2018 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Oct 6, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 13, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 13, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 29, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 29, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 16, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 21, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 21, 2018 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 6, 2018 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Feb 6, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 6, 2018 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Feb 6, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 6, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 23, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 22, 2018 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jan 22, 2018 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 22, 2018 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jan 21, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 27, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 21, 2017 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 20, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 7, 2017 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 27, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 27, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jun 9, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 25, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 18, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 28, 2017 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Feb 10, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 9, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 9, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 9, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 8, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 16, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 15, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 12, 2016 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 1, 2016 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |